Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-179-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Justification of read-across: Both chemicals are of comparable structures with minor deviations and can be characterized as an ester of sorbitan and a fatty acid. Justification of reliability of 2: Comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- analytical purity of test substance not reported
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Sorbitan stearate
- EC Number:
- 215-664-9
- EC Name:
- Sorbitan stearate
- Cas Number:
- 1338-41-6
- IUPAC Name:
- 1,4-anhydro-6-O-stearoyl-D-glucitol
- Reference substance name:
- Sorbitan, monooctadecanoate
- IUPAC Name:
- Sorbitan, monooctadecanoate
- Reference substance name:
- SPAN 60
- IUPAC Name:
- SPAN 60
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Sorbitan, monooctadecanoate (SMO)
- Physical state: yellow crystalline pellet
- Analytical purity: no data
- Stability under test conditions: verified
- Storage condition of test material: sealed and kept at room temperature
Constituent 1
Constituent 2
Constituent 3
Method
- Target gene:
- his operon
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- SD rat liver S9 mix
- Test concentrations with justification for top dose:
- ge-finder: 0, 50, 150, 500, 1500, 5000 µg/plate
Main study: 0, 313, 625, 1250, 2500, 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive control substance:
- 9-aminoacridine
- sodium azide
- other: (2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide), 2-Aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: 20 minutes
- Exposure duration: 48 hours
NUMBER OF REPLICATIONS: 3
two independent experiments were performed, each in triplicate
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Statistics:
- If the average number of colonies on plates containing the test substance increased more than twice the negative control, the test is considered positive.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: at concentration of 625 µg/plate (without S9) and at 1250 µg/plate (with S9) and higher concentrations in both experiments.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Cytotoxicity was observed at precipitating concentrations - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
The analogue approach using sorbitan stearate as source chemical is justified:
Both chemicals are of comparable structures with minor deviations and can be characterized as an ester of sorbitan and a fatty acid. Compared to the source chemical, the target chemical has a shorter alkyl chains that affect its physicochemical properties. But based on the kinetic / metabolic investigations on both chemicals, the length of the alkyl chain is not considered to have significant impact on the metabolic pathway or toxicological mode of action. Oral gavage studies in rats administered C14 labeled sorbitan stearate in oil solutions have demonstrated that about 90% of the substance was absorbed and hydrolyzed to stearic acid and sorbitan. The metabolic fate of sorbitan caprylate was investigated using a lipase assay. The hydrolysis mediated by porcine pancreas lipase was quantitatively determined. The target chemical sorbitan caprylate is proved to be hydrolyzed and caprylic acid was formed . These findings suggest that metabolism of the sorbitan occur initially via enzymatic hydrolysis, leading to sorbitan and the corresponding natural acids.
Based on the above mentioned information, it is reasonable to consider that these two substances are comparable in their metabolic fate and thereby toxicological profiles. Hence, the source chemical is considered as “suitable with interpretation” analog.
According to the available toxicity studies, the findings are also comparable for target and source chemicals:
· The findings in acute toxicity studies are comparable. Both chemicals are of no acute toxicity.
· The findings in subacute dose toxicity studies are comparable. No treatment effects were observed in 28-day repeated toxicity studies in Wistar rats. The same NOEL of 1000 mg/kg bw/d was derived for both chemicals.
· The findings in genetic toxicity are comparable. Both chemicals did not induce gene mutations in Ames tests, but induced structural chromosomal aberrations in cell lines of Chinese Hamster.
· The findings in reproduction / developmental toxicity studies are comparable.
Table 1: Summary of Ames Test result (experiment 1)
Maximum number of revertants |
||||||
solvent control |
positive control |
treatment (at dose level [µg/plate]) |
||||
Strain |
With S9 |
Without S9 |
With S9 |
Without S9 |
With S9 |
Without S9 |
TA 100 |
161 |
139 |
818 |
512 |
166 (313) |
135 (1250) |
TA 1535 |
13 |
13 |
378 |
641 |
12 (1250) |
13 (625) |
WP2 uvrA |
25 |
26 |
951 |
113 |
35 (313 and 5000) |
27 (625) |
TA 98 |
39 |
23 |
374 |
457 |
40 (625) |
26 (1250) |
TA 1537 |
18 |
7 |
152 |
321 |
19 (1250) |
10 (1250) |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
It can be concluded that under the experimental conditions reported, the test item did not induce gene mutations in the genome of the strains used. - Executive summary:
The genetic toxicity of sorbitan caprylate was assessed based on the analogue approach using sorbitan monostearate as a read-across supporting substance.
The gene mutation potential of Sorbitan monostearate was investigated in the plate using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strain WP2 uvrA.The assay was performed iboth with and without liver microsomal activation. The test item was tested at the following concentrations:
313; 625; 1250; 2500; and 5000 µg/plate.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with sorbitan monostearate at any dose level, neither in the presence nor absence of metabolic activation (S9 mix).
It can be concluded that under the experimental conditions reported, the test item did not induce gene mutations in the genome of the strains used.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
